| 2.19 -0.013 (-0.58%) | 10-23 11:28 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.83 | 1-year : | 3.06 |
| Resists | First : | 2.42 | Second : | 2.61 |
| Pivot price | 2.24 |
|||
| Supports | First : | 2.1 | Second : | 1.75 |
| MAs | MA(5) : | 2.17 | MA(20) : | 2.24 |
| MA(100) : | 2.07  |
MA(250) : | 2.09 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 15.6 |
D(3) : | 14.5 |
| RSI | RSI(14): 47.3 |
|||
| 52-week | High : | 4.03 | Low : | 1.63 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ FORA ] has closed above bottom band by 31.8%. Bollinger Bands are 26.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.3 - 2.32 | 2.32 - 2.33 |
| Low: | 2.11 - 2.12 | 2.12 - 2.14 |
| Close: | 2.17 - 2.19 | 2.19 - 2.21 |
Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.
Wed, 03 Sep 2025
Earnings call transcript: Forian Inc Q2 2025 beats revenue forecast, stock dips - Investing.com
Mon, 25 Aug 2025
Forian Inc. Receives Unsolicited Take-Private Proposal from CEO-Led Consortium - citybuzz -
Mon, 25 Aug 2025
Forian Receives Proposal to Go Private - TipRanks
Wed, 13 Aug 2025
Forian Q2 2025 slides: First profitable quarter with 56% revenue growth - Investing.com
Mon, 16 Jun 2025
Forian Inc. Expands Equity Incentive Plan by 4 Million Shares - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 31 (M) |
| Shares Float | 9 (M) |
| Held by Insiders | 51.9 (%) |
| Held by Institutions | 13.5 (%) |
| Shares Short | 84 (K) |
| Shares Short P.Month | 87 (K) |
| EPS | -0.03 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.99 |
| Profit Margin | -3.7 % |
| Operating Margin | 0.6 % |
| Return on Assets (ttm) | -4.8 % |
| Return on Equity (ttm) | -3.3 % |
| Qtrly Rev. Growth | 56.5 % |
| Gross Profit (p.s.) | 0.47 |
| Sales Per Share | 0.8 |
| EBITDA (p.s.) | -0.13 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 3 (M) |
| Levered Free Cash Flow | 3 (M) |
| PE Ratio | -72.67 |
| PEG Ratio | 0 |
| Price to Book value | 2.2 |
| Price to Sales | 2.7 |
| Price to Cash Flow | 25.88 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|